IP Advantage Leverage Hologic's strong IP position in breast cancer detection following a significant patent victory against Siemens to pursue licensing or collaboration opportunities with imaging centers, diagnostics labs, and strategic partners worldwide.

AI Imaging Leadership Highlight AI-driven breast cancer detection technologies and 3D mammography capabilities demonstrated at industry events such as SBI Symposium and ASCO 2026, and position these as solutions to radiology departments, screening programs, and cancer centers seeking improved diagnostic accuracy.

Nearshoring Advantage Hologic Costa Rica's regional footprint with a mid-sized workforce enables nearshoring opportunities for Latin American markets; engage regional hospitals, imaging centers, and distributors to secure reliable supply of breast health, diagnostic, and GYN surgical equipment with shorter lead times.

Women’s Health Focus With a clear focus on women's health and a diversified pipeline spanning breast and skeletal health, diagnostics, GYN surgical solutions, and medical aesthetics, pursue opportunities with hospitals, clinics, and payers investing in women's health programs and preventive screening initiatives.

Leadership Momentum Leadership pivot with the appointment of José (Joe) E. Almeida as CEO in 2026 signals strategic renewal; pair this with ongoing ASCO and SBI industry engagement to secure executive briefings and accelerate partnerships with healthcare networks, cancer centers, and government health programs seeking next-generation breast health solutions.